| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |